Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Google backs Indian mobile online doctor community

Curofy wins support from the firm's Launchpad Accelerator programme

Digital pharma CurofyA new online mobile network for doctors is among the startups to receive the backing of Google's Launchpad Accelerator programme.

Curofy claims to be India's largest online community of verified doctors, with over 190,000 members from more than 600 cities.

Its flagship app, which is available for both Apple and Android devices, allows them to discuss medical cases and provides access to medical news and jobs. 

Curofy's co-founder Pawan Gupta told BWDisrupt: "Google Accelerator provides a great opportunity for Indian startups to be mentored in best product and engineering practices followed in Silicon Valley. The learning and exposure from the accelerator will prepare Curofy's product for its growth beyond India".

As it does so one of its competitors will likely be MedShr, which was launched last year by a UK doctor as a similarly mobile-first social work.

Curofy, which is based near New Delhi in Gurgaon, joins the third wave of startups in the Google's Launchpad programme, among them a word game app and one for CRM.

The companies are now inline for six months mentorship and a share of $50,000 in equity-free funding.

20th December 2016

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics